Browsing Tag
Sofinnova Partners
4 posts
How NanoPhoria’s record €83.5m raise could transform heart failure treatment—and put Italian biotech on the global map
NanoPhoria Bioscience raises €83.5M to advance its novel heart-failure therapy and expand its nano delivery platform. Find out how it’s changing biotech today.
Bioptimus hits major funding milestone, unveils plans for transformative biology model
Bioptimus, a Paris-based leader in artificial intelligence innovation, has reached a remarkable funding milestone of $76 million, underscoring…
Gradient Denervation raises €14m for pulmonary hypertension treatment
Gradient Denervation Technologies has successfully closed a €14 million Series A financing round to support the clinical development…
French biotech company Amolyt Pharma Series C round fetches $138m
Amolyt Pharma, a France-based clinical-stage biotechnology company, has secured €130 million (around $138 million) from a Series C…